{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:42:43Z","timestamp":1787640163452,"version":"build-2736575974"},"reference-count":34,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLEP"],"DOI":"10.2147\/clep.s558429","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:50:10Z","timestamp":1765000210000},"page":"1025-1038","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of Epidemiological Estimates for 19 Cancer Types Using Electronic Health Record Databases in England: An Analysis of CPRD Aurum and CPRD GOLD Databases with Linked Hospital Episode Statistics and Cancer Registry Data"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Anna","family":"Chaplin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olia","family":"Archangelidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2407-2995","authenticated-orcid":true,"given":"Katrina","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Neasham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7871-9216","authenticated-orcid":true,"given":"George","family":"Kafatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,12]]},"reference":[{"key":"ref1","unstructured":"Medicines and Healthcare products Regulatory Agency. Clinical practice research datalink. Available from: https:\/\/www.cprd.com\/. Accessed October 31, 2025."},{"key":"ref2","unstructured":"Medicines and Healthcare products Regulatory Agency. Primary care data for public health research. Available from: https:\/\/www.cprd.com\/primary-care-data-public-health-research. Accessed October 31, 2025."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.21037\/ace-22-4","volume":"6","author":"Hagberg","year":"2022","journal-title":"Ann Cancer Epidemiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2147\/CLEP.S434795","volume":"15","author":"Hagberg","year":"2023","journal-title":"Clin Epidemiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyz034","volume":"48","author":"Wolf","year":"2019","journal-title":"Int J Epidemiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"ref7","unstructured":"Medicines and Healthcare products Regulatory Agency. CPRD linked data. Available from: https:\/\/www.cprd.com\/cprd-linked-data. Accessed October 31, 2025."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","volume":"23","author":"Jick","year":"2003","journal-title":"Pharmacotherapy"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/art.24015","volume":"59","author":"Thomas","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","volume":"69","author":"Herrett","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.3399\/bjgp10X483562","volume":"60","author":"Khan","year":"2010","journal-title":"Br J Gen Pract"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/pds.5135","volume":"29","author":"Persson","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/pds.5551","volume":"32","author":"Vasilakis-Scaramozza","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2147\/CLEP.S434829","volume":"15","author":"Hagberg","year":"2023","journal-title":"Clin Epidemiol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/pds.3374","volume":"22","author":"Boggon","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.canep.2018.08.009","volume":"57","author":"Arhi","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"102715","DOI":"10.1016\/j.canep.2024.102715","volume":"94","author":"Somathilake","year":"2025","journal-title":"Cancer Epidemiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.canep.2012.05.013","volume":"36","author":"Dregan","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/pds.3729","volume":"24","author":"Ra\u00f1opa","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2147\/CLEP.S434832","volume":"15","author":"Jick","year":"2023","journal-title":"Clin Epidemiol"},{"key":"ref21","unstructured":"Medicines and Healthcare products Regulatory Agency. CPRD Aurum December 2024 (Version 2024.12.001). Accessed October 31, 2025. doi:10.48329\/qfkt-kb64"},{"key":"ref22","unstructured":"Medicines and Healthcare products Regulatory Agency. CPRD GOLD December 2024 (Version 2024.12.001). Accessed October 31, 2025. doi:10.48329\/se5g-a206"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ije\/dyz076","volume":"49","author":"Henson","year":"2020","journal-title":"Int J Epidemiol"},{"key":"ref24","unstructured":"NHS England. Hospital Episode Statistics (HES) and Office for National Statistics (ONS). linked mortality data guide; 2025. Available from: https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/linked-hes-ons-mortality-data\/hes-and-ons-linked-mortality-data-guide. Accessed October 31, 2025."},{"key":"ref25","unstructured":"Cancer Research UK. Acute myeloid leukaemia (AML) incidence statistics; 2025. Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/leukaemia-aml\/incidence?_gl=1*xrmml*_gcl_au*MTcxODQ5NDQwNS4xNzUzMDg3MDMx*_ga*MTMwNTk3NTI2NC4xNzUzMDg3MDMx*_ga_58736Z2GNN*czE3NTMwODcwMzEkbzEkZzEkdDE3NTMwODcxMDEkajUyJGwwJGgw. Accessed October 31, 2025."},{"key":"ref26","unstructured":"Cancer Research UK. Stomach cancer incidence statistics; Available from: 2025. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/stomach-cancer\/incidence#heading-Two. Accessed October 31, 2025."},{"key":"ref27","unstructured":"Cancer Research UK. Ovarian cancer incidence statistics; Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer\/incidence#heading-Two. Accessed October 31, 2025."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"102703","DOI":"10.1016\/j.canep.2024.102703","volume":"94","author":"Whitfield","year":"2025","journal-title":"Cancer Epidemiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/EDE.0000000000000786","volume":"29","author":"Margulis","year":"2018","journal-title":"Epidemiology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s12885-018-4417-3","volume":"18","author":"Di Girolamo","year":"2018","journal-title":"BMC Cancer"},{"key":"ref31","unstructured":"NHS Improvement. Ensuring better treatment: going further on cancer waits. Available from: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/sites\/44\/2017\/11\/Going-Further-on-Cancer-Waits.pdf. Accessed October 31, 2025."},{"key":"ref32","unstructured":"NHS England. Quality and outcomes framework. Available from: https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/general-practice-data-hub\/quality-outcomes-framework-qof. Accessed October 31, 2025."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41416-024-02931-0","volume":"132","author":"Stannard","year":"2025","journal-title":"Br J Cancer"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41416-022-01718-5","volume":"126","author":"Delon","year":"2022","journal-title":"Br J Cancer"}],"container-title":["Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/109629","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/109629","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:50:14Z","timestamp":1765000214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/comparison-of-epidemiological-estimates-for-19-cancer-types-using-elec-peer-reviewed-fulltext-article-CLEP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":34,"URL":"https:\/\/doi.org\/10.2147\/clep.s558429","relation":{},"ISSN":["1179-1349"],"issn-type":[{"value":"1179-1349","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}